ArticleJournal of gastrointestinal cancer2026
Global Burden and Future Trends of Gastrointestinal Cancers in Adolescents and Young Adults, 1990-2045: A Predictive Analysis.
Article in Journal of gastrointestinal cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
purposeGastrointestinal (GI) cancers significantly contribute to the global cancer burden, yet their epidemiological trends among adolescents and young adults (AYAs: aged 15-39 years) remain understudied. This study provides the first comprehensive analysis of global burden, temporal trends (1990-2021), and projections to 2045 for GI cancers in AYAs.
methodsUsing the Global Burden of Disease (GBD) 2021 dataset, we analyzed age-standardized incidence rates (ASIR), death rates (ASDR), disability-adjusted life-years (DALYs), and estimated annual percentage changes (EAPC). Bayesian age-period-cohort modeling was employed for projections to 2045.
resultsIn 2021, there were 156,033 new GI cancer cases, 84,623 deaths, and 4.9 million DALYs among AYAs globally. From 1990 to 2021, ASIR for colorectal and gallbladder cancers increased (EAPCs:0.55[95%CI:0.44, 0.67] and 0.13[0.05, 0.20], respectively), while ASIR for other GI cancers declined (e.g., stomach cancer:-2.75 [- 2.94, - 2.57]). East Asia bore the highest burden. Projections suggest a stabilization of overall ASIR and ASDR by 2045, though liver and gallbladder cancers are expected to rise.
conclusionsThe burden of GI cancers among AYAs remains substantial and is projected to persist, highlighting the need for targeted early-detection strategies and age-specific prevention programs, especially in high-risk regions.
Indexed as
Identifiers
41528577What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.